ONPH is exploring strategic partnerships and opportunities in oncology

Our Portfolio (Licences)

Nanosmart Pharmaceuticals  -  
NanoSmart's® platform technology  (US  Patent No: 7,799,327 and EU 1706145 B1)

Tulynode  -   

Tulynode's "patent pending" Autologous Cellular Immuno-therapy extracorporeal device

Licences

1 Sansome Street, Suite 3500

San Francisco, CA 94104

info@oncology-pharma.com

 

415-869-1036

  • White LinkedIn Icon
  • White Facebook Icon
  • White Twitter Icon
  • White Google+ Icon
Send Us a Message

© 2019 by Oncology Pharma Inc.